ENDOTHELIAL DYSFUNCTION AND SYSTEMIC INFLAMMATION AS SEVERITY STRATIFICATION FACTORS OF CROHN’S DISEASE

E A Stepina

doi:10.17816/pmj33153-58

Perm Medical Journal ›› 2016, Vol. 33 ›› Issue (1) :53 -58. DOI: 10.17816/pmj33153-58

Articles

research-article

ENDOTHELIAL DYSFUNCTION AND SYSTEMIC INFLAMMATION AS SEVERITY STRATIFICATION FACTORS OF CROHN’S DISEASE

E A Stepina

Author information +

History +

PDF

Abstract

Aim. The aim of the study was to determine the functional activity of endothelium in patients with Crohn’s disease (CD), and to assess its dependence on the severity of disease attack. Materials and methods. Sixteen patients diagnosed CD in the exacerbation phase and those with first diagnosed forms of disease were examined. The control group enclosed 11 practically healthy persons. The blood serum vasculoendothelial growth factor (VEGF) level, plasma desquamated endotheliocytes (DEC) number, as well as microalbuminuria (MAU) level were studied as the markers of endothelial dysfunction (ED). Results. Among CD patients, increased concentrations of ED markers as compared with the control group were revealed. A reliable correlation between the ED indices and the degree of severity of the disease was obtained. Positive correlation between the VEGF, DEC and MAU levels and the systemic inflammation markers (ESR, SRP, fibrinogen and alpha-2-globulin) was found. A mathematical model allowing to predict the degree of severity of CD attack was developed. Conclusions. Endothelial dysfunction, which is expressed by the increased VEGF, DEC and MAU levels, was detected in CD patients. ED indices directly depend on the serum markers of systemic inflammation. Thus, VEGF, DEC and MAU values can serve as a criterion for CD attack severity.

Keywords

Endothelial dysfunction / Crohn’s disease / vasculoendothelial growth factor (VEGF) / desquamated endotheliocytes / microalbuminuria

Cite this article

Download citation ▾

E A Stepina. ENDOTHELIAL DYSFUNCTION AND SYSTEMIC INFLAMMATION AS SEVERITY STRATIFICATION FACTORS OF CROHN’S DISEASE. Perm Medical Journal, 2016, 33(1): 53-58 DOI:10.17816/pmj33153-58

登录浏览全文

4963

注册一个新账户忘记密码

References

Publishing order | Descend order by publishing year | Descend order by cited within

[1]	Алексеева Е.А., Копосова К.А., Хлынова О.В. «Пермский вариант» воспалительных заболеваний кишечника. Дневник Казанской медицинской школы 2013; 1: 82.

[2]	Белоусова Е.А. Рекомендации по диагностике и лечению болезни Крона. Фарматека 2009; 13: 38-44.

[3]	Бойко Т.И., Стойкевич М.В., Колбасина Е.В., Сорочан Е.В. Состояние функции сосудистого эндотелия у больных с хроническими воспалительными заболеваниями кишечника. Сучасна гастроентерологія. 2010; 1(51): 5-10.

[4]	Ивашкин В.Т. и соавт. Рекомендации по диагностике и лечению взрослых пациентов с болезнью Крона. М. 2013; 23.

[5]	Реброва О.Ю. Статистический анализ медицинских данных. Применение прикладных программ STATISTICA. М.: МедиаСфера 2003; 312.

[6]	Румянцев В.Г., Фомин С.А., Киркин Б.В. Ишемия в патогенезе язвенного колита у пожилых. Тезисы VI Европейского конгресса геронтологов. М. 2002.

[7]	Халиф И.Л., Лоранская И.Д. Воспалительные заболевания кишечника (неспецифический язвенный колит и болезнь Крона): клиника, диагностика и лечение. М.: Миклош 2004; 88.

[8]	Шишкин А.Н., Лындина М.Л. Эндотелиальная дисфункция и артериальная гипертензия. Артериальная гипертензия 2008; 4: 315-319.

[9]	Baumgart D.C., Sandborn W.J. Crohn's disease. Lancet 2012; 380 (9853): 1590-1605.

[10]	Hladovec J. Circulating endothelial cells as a sign of vessel wall lesion. Physiol Bohemoslov 1978; 27: 140-144.

[11]	Ferrante M., Pierik M., Henckaerts L., Joossens M. The role of vascular endothelial growth factor (VEGF) in inflammatory bowel disease. Inflamm. Bowel. Dis. 2006; 12 (9): 870-878.

[12]	Kopanakis N., Saiti A., D'Avgerinos E., Masselou K. Serum VEGF and bFGF in patients with inflammatory bowel diseases. Ann. Ital. Chir. 2014; 85 (3): 203-206.